Study of the Safety and Efficacy of MLN1202 in Patients in Multiple Sclerosis

Clinical trial NCT01199640 · COMPLETED

Trial details

NCT number: NCT01199640
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Multiple Sclerosis

Start date: 2005-05-01
Primary completion: 2007-07-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.